Catalog · Industry and sector · D13
Healthcare, Pharma and Biotech (Part 2): Pharma Manufacturing and Clinical Delivery
For pharmaceutical manufacturers, medical device firms and digital health businesses. Clinical content is awareness level and does not substitute for licensed clinical training.
10 Capability Courses · 8 Foundation · 2 Intermediate
Capability Courses in this group
| Code | Capability Course | Level |
|---|---|---|
| IN-HCL2-101 | Global Regulatory Frameworks for Pharma Manufacturing and Clinical Delivery | Foundation |
| IN-HCL2-102 | Integrating Regulatory Strategy into Manufacturing and Clinical Operations | Foundation |
| IN-HCL2-103 | Medical Legal Regulatory (MLR) Review in Global Pharma | Foundation |
| IN-HCL2-104 | Navigating Regulatory Pathways | Foundation |
| IN-HCL2-105 | Implementing GMP and GCP | Intermediate |
| IN-HCL2-106 | Aligning Clinical Operations and Manufacturing for Product Launch and Lifecycle | Intermediate |
| IN-HCL2-107 | Informed Consent, Data Protection, and Post Market Surveillance | Foundation |
| IN-HCL2-108 | Managing Cross-Functional Teams for Regulatory Submissions and Lifecycle Oversight | Foundation |
| IN-HCL2-109 | Jurisdictional Differences in Sourcing, Manufacturing, Clinical Trials, and Pharmacovigilance | Foundation |
| IN-HCL2-110 | Optimizing Workforce Planning and Resource Allocation for Global Operations | Foundation |
More in Industry and sector
Related groups
See Healthcare, Pharma and Biotech (Part 2) mapped to your organization.
A short walkthrough of these Capability Courses, the platform, and your deployment options.